Towards Healthcare
Hematology Analyzers Market Size Climbs USD 4.33 Billion in 2025

Hematology Analyzers Market 2025 Drives by AI Integration, CBC Dominance & POCT Expansion

According to market projections, the global hematology analyzers market, valued at USD 4.08 billion in 2024, is anticipated to reach USD 7.28 billion by 2034, growing at a CAGR of 5.97% over the next decade. Majorly impacting factors like rising prevalence of blood disorders such as anaemia, thalassemia, leukemia, and progressing innovations in pharmacogenomics, stem cell research are driving the market growth. Whereas, North America was dominant in the hematology analyzers market due to high diagnostic volumes, chronic disease screening, and centralized lab chain

Content

  • Insight Code: 5838
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The hematology analyzers market is projected to reach USD 7.28 billion by 2034, growing at a CAGR of 5.97% from 2024 to 2034.

North America is currently leading the hematology analyzers market due to high diagnostic volumes, chronic disease screening, and centralized lab chains.

The hematology analyzers market includes 6 segments, such as by product type, by technology, by application, by end user, by modality, and by region etc.

Some key players include Sysmex Corporation, Beckman Coulter (Danaher Corporation), Abbott Laboratories, Siemens Healthineers, and Horiba Ltd. 

Key trends include rising demand for advanced diagnostic equipment and POCT, growth in investments in healthcare infrastructure, and innovation in automated and AI-driven technologies in hematology.

A hematology analyzer provides information regarding CBC, differential WBC count, red blood cell indices, and platelet parameters.

Hematology analyzer has some common faults like counting small hole blockage, aspiration needle blockage, pump tube aging, filter is not smooth, directional valve failure, solenoid valve blockage, waste liquid cup accumulation, insufficient reagent volume, and sample volume shortage, and so on.

The main purpose of hematology includes blood and bone marrow cells. Also, hematological tests support to diagnosis of anemia, infection, hemophilia, blood-clotting disorders, and leukemia.

NIH.GOV, CDC.GOV, US FDA. GOV, PIB.GOV, MoHFW, ICMR, ISHBT, ASH.GOV, ACTREC.GOV
Any Questions